Reply to Letter to the Editor for a Research Paper Entitled “Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention”
Restricted accessLetterFirst published online July, 2024
Reply to Letter to the Editor for a Research Paper Entitled “Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention”
HuH-LWangY-YJingD-TZhuF. Galectin-3 as a novel biomarker of predicting prognosis in patients with coronary artery disease. Angiology. 2024;75:598-599.
2.
KöktürkUPüşüroğluHSomuncuMU, et al.Short and long-term prognostic significance of galectin-3 in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2024;75:600.
3.
LiuFTRabinovichGA. Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci. 2010;1183:158-82.
4.
ElolaMTWolfenstein-TodelCTroncosoMFVastaGRRabinovichGA. Galectins: matricellular glycan-binding proteins linking cell adhesion migration, and survival. Cell Mol Life Sci. 2007;64:1679-700.
5.
FalconeCLucibelloSMazzucchelliI, et al.Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome. Int J Immunopathol Pharmacol. 2011;24:905-13.
